2012
DOI: 10.1016/j.actatropica.2012.08.003
|View full text |Cite
|
Sign up to set email alerts
|

Therapeutic battle against larval toxocariasis: Are we still far behind?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
48
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 56 publications
(51 citation statements)
references
References 59 publications
3
48
0
Order By: Relevance
“…In addition, the immunopathological response may differ among patients and symptoms and signs may undergo remission in treated and placebo-treated patients. Therefore, the dose rates of drugs and length of treatment differ among patients (Othman 2012).…”
Section: Medical Treatmentmentioning
confidence: 99%
“…In addition, the immunopathological response may differ among patients and symptoms and signs may undergo remission in treated and placebo-treated patients. Therefore, the dose rates of drugs and length of treatment differ among patients (Othman 2012).…”
Section: Medical Treatmentmentioning
confidence: 99%
“…Ocular toxocariasis is associated with vision loss, especially among children living in the South [21]. Given the high rates of toxocariasis among people living in the southern US and its association with cognitive delays, epilepsy, vision loss, and reduced pulmonary function, there is an urgent need to conduct prospective studies to confirm these links as well as to evaluate potential therapies with albendazole and other anthelminthic drugs [22]. The extent to which other soil-transmitted helminth infections still occur in the US is not known.…”
Section: Neglected Helminthic Infectionsmentioning
confidence: 99%
“…Some authors agree that treatment is needed when patients' symptoms are severe. 13,23,24 In ELA-T was simultaneously identified and pathologically confirmed in one case with renal cell carcinoma at the time of initial diagnosis; in this patient, effect of cancer or surgery on the development and outcome of ELA-T could not be ruled out.…”
Section: -47mentioning
confidence: 99%
“…23 Treatment of ELA-T depends on the severity of the patient's symptoms and the clinician's decision. Some authors agree that treatment is needed when patients' symptoms are severe.…”
Section: -47mentioning
confidence: 99%